Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001593318-13-000001
Filing Date
2013-12-03
Accepted
2013-12-03 12:54:33
Documents
1
Effectiveness Date
2013-12-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9073
  Complete submission text file 0001593318-13-000001.txt   10165
Mailing Address 260 LITTLEFIELD AVENUE SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 235-4140
Reset Therapeutics, Inc. (Filer) CIK: 0001593318 (see all company filings)

EIN.: 711047315 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-207293 | Film No.: 131253842